Found: 6
Select item for more details and to access through your institution.
Efficacy and safety of subcutaneous tocilizumab in rheumatoid arthritis over 1 year: a UK real-world, open-label study.
- Published in:
- Rheumatology Advances in Practice, 2019, v. 3, n. 1, p. N.PAG, doi. 10.1093/rap/rkz010
- By:
- Publication type:
- Article
Tapering versus steady-state methotrexate in combination with tocilizumab for rheumatoid arthritis: a randomized, double-blind trial.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. 84, doi. 10.1093/rheumatology/kex358
- By:
- Publication type:
- Article
The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic review.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic review.
- Published in:
- Rheumatology, 2012, v. 51, n. 12, p. 2252, doi. 10.1093/rheumatology/kes217
- By:
- Publication type:
- Article
Healthcare Resource Use and Costs Associated with Organ Damage in Newly Diagnosed Adults with Systemic Lupus Erythematosus in the UK.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 5, p. 1183, doi. 10.1007/s40744-023-00567-9
- By:
- Publication type:
- Article
Adverse Outcomes, Healthcare Resource Utilization, and Costs Associated with Systemic Corticosteroid use Among Adults with Systemic Lupus Erythematosus in the UK.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 5, p. 1167, doi. 10.1007/s40744-023-00566-w
- By:
- Publication type:
- Article